LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 7.77 | 84.90 | 1063 | 411 | 2.5849 | 2.0355 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 9.47 | 84.90 | 2 | 447 | 0.0045 | -0.7905 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 9.47 | 84.90 | 731 | 447 | 1.6338 | 1.4544 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 9.47 | 84.90 | 6 | 447 | 0.0134 | -0.6688 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 9.47 | 84.90 | 1135 | 447 | 2.5367 | 1.9487 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 11.18 | 84.90 | 3 | 492 | 0.0061 | -0.7324 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 11.18 | 84.90 | 773 | 492 | 1.5700 | 1.3893 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 11.18 | 84.90 | 13 | 492 | 0.0264 | -0.5229 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 11.18 | 84.90 | 1208 | 492 | 2.4535 | 1.8493 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 12.88 | 84.90 | 3 | 531 | 0.0056 | -0.7174 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 12.88 | 84.90 | 835 | 531 | 1.5725 | 1.3733 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 12.88 | 84.90 | 22 | 531 | 0.0414 | -0.3998 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 12.88 | 84.90 | 1273 | 531 | 2.3974 | 1.7836 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 14.58 | 84.90 | 1 | 663 | 0.0015 | -0.7763 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 14.58 | 84.90 | 893 | 663 | 1.3461 | 1.2108 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 14.58 | 84.90 | 26 | 663 | 0.0392 | -0.3290 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 14.58 | 84.90 | 1361 | 663 | 2.0515 | 1.5483 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 16.29 | 84.90 | 5 | 766 | 0.0065 | -0.5901 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 16.29 | 84.90 | 981 | 766 | 1.2792 | 1.1613 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 16.29 | 84.90 | 40 | 766 | 0.0522 | -0.2110 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 16.29 | 84.90 | 1437 | 766 | 1.8739 | 1.4374 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 17.99 | 84.90 | 12 | 898 | 0.0133 | -0.4371 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 17.99 | 84.90 | 1057 | 898 | 1.1758 | 1.0974 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 17.99 | 84.90 | 57 | 898 | 0.0634 | -0.1104 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 17.99 | 84.90 | 1558 | 898 | 1.7331 | 1.3506 | MN20160318_Q02 | I21 |